JOURNAL ARTICLE
Add like
Add dislike
Add to saved papers

Mohs micrographic surgery for an erosive adenomatosis of the nipple.

BACKGROUND: Erosive adenomatosis of the nipple is a rare but distinct benign tumor of the nipple. It is usually considered to be derived from the apocrine sweat ducts of the nipple epithelium but probably of lactiferous duct origin. Total excision is the treatment of choice.

OBJECTIVE: We report the clinical and histological features of this rare tumor, and the surgical technique employed.

METHODS: Treatment consisted of Mohs micrographic surgery (MMS), fresh tissue technique, followed by primary closure.

RESULTS: The described procedure resulted in a cure of the erosive adenomatosis of the nipple.

CONCLUSION: Total excision of erosive adenomatosis of the nipple can be obtained by MMS. This technique prevents recurrence of the disease and minimizes resulting deformation of this important anatomic area.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app